Trial Profile
Clinical Trials Insight: 700055463
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 19 Apr 2010
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Postmenopausal osteoporosis
- Focus Adverse reactions
- Sponsors Emisphere Technologies
- 19 Apr 2010 New trial record